About This Study
The purpose of this study is to see if the study drug, Frexalimab, can keep multiple sclerosis from getting worse. We also want to learn more about the side effects that may be caused by the study drug.
Need volunteers diagnosed with secondary progressive multiple sclerosis with no relapses. Taking part in this study will last for at least 12 months up to approximately 58 months. The study drug will be given through an IV infusion. Study team will discuss study details with you.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 60 years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- No reimbursement offered
Study Locations
- Greater Winston-Salem, NC